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Turbodynamic left ventricular assist devices (LVADs) pro-
vide a continuous flow depending on the speed at which the 
pump is set, and do not adapt to the changing requirements 
of the patient. The limited adaptation of the pump flow (PF) 
to the amount of venous return can lead to ventricular suc-
tion or overload. Physiologic control may compensate such 
situations by an automatic adaptation of the PF to the vol-
ume status of the left ventricle. We evaluated two physiologic 
control algorithms in an acute study with eight healthy pigs. 
Both controllers imitate the Frank–Starling law of the heart 
and are based on a measurement of the left ventricular vol-
ume (LVV) or pressure (LVP), respectively. After implantation 
of a modified Deltastream DP2 blood pump as an LVAD, we 
tested the responses of the physiologic controllers to hemo-
dynamic changes and compared them with the response of 
the constant speed (CS) mode. Both physiologic controllers 
adapted the pump speed (PS) such that the flow was more 
sensitive to preload and less sensitive to afterload, as com-
pared with the CS mode. As a result, the risk for suction was 
strongly reduced. Five suction events were observed in the CS 
mode, one with the volume-based controller and none with 
the pressure-based controller. The results suggest that both 
physiologic controllers have the potential to reduce the num-
ber of adverse events when used in the clinical setting. ASAIO 
Journal 2017; 63:568–577.
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lar assist device
Despite great technical and clinical improvements, left ven-
tricular assist device (LVAD) therapy is still affected by many 
adverse events like strokes, right ventricular (RV) failure, bleed-
ing, hemolysis, or driveline infection.1 Some of these adverse 
events are thought to be promoted by the nonphysiologic 
response of the LVAD operated at constant speed (CS). How-
ever, the direct hemodynamic effects are well understood, the 
clinical consequences of these are mainly assumptions: when 
the pump flow (PF) is higher than the blood return to the heart, 
the LV is emptied by the pump, and eventually, ventricular suc-
tion, that is, a collapse of the ventricular walls occurs. Ven-
tricular suction presumably promotes hemolysis and thrombus 
formation because of flow stasis and damage to the myocar-
dium, which may be sucked onto the pump inlet.2 In addition, 
excessive unloading of the LV may lead to a septum shift, which 
impairs the functioning of the RV and may cause a tricuspid 
valve insufficiency, which in turn may lead to RV failure.3 In 
contrast, when the PF is lower than the blood return and the 
LV itself is too weak to generate more flow, the LV is over-
loaded and a congestion of blood in the left atrium (LA) and 
the pulmonary circulation occurs.4 Left ventricular overload 
may additionally injure the already failing LV because of a con-
secutive increase in wall tension. Furthermore, the increased 
pulmonary pressure caused by the congestion of blood may, 
in extreme cases, lead to lung edema and imposes an exces-
sive load on the RV. Physiologic control may have the potential 
to reduce the number of adverse events by adaptation of the 
pump speed (PS) and, thus, prevention of suction or overload.
Many physiologic controllers have been analyzed in silico 
or in vitro and were presented in the literature, but only few 
controllers were also tested in vivo. The in vivo studies can be 
subdivided into four categories: first, studies which collected in 
vivo data, for example, during a PS ramp, and then proposed a 
physiologic controller after the analysis of this data.5–11 Second, 
studies with suction detection and prevention algorithms.12–17 
Third, studies in which the PS is pulsed in synchrony with the 
cardiac cycle.18–24 And fourth, studies with physiologic control-
lers activated in vivo (animals or human patients).25–30 Of all 
four categories, only the last represents the case of a closed 
feedback loop, which is an important difference, because feed-
back can lead to instability. No chronic in vivo experiments 
with activated physiologic controllers are found in the literature.
We have also presented two physiologic controllers in previ-
ous in vitro studies: The preload responsive speed (PRS) controller 
adjusts the PS based on a measurement of the LV volume (LVV),31 
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whereas the systolic pressure (SP) controller adjusts the PS based 
on a measurement of the LV pressure (LVP).32 The purpose of both 
controllers is the imitation of the Frank–Starling law of the heart, 
which states that the flow generated by the healthy ventricle 
mainly depends on its preload.33 The pressure-flow characteris-
tics of a turbodynamic LVAD operated at CS differs greatly from 
that of a healthy heart. Compared with a healthy LV, the sensitiv-
ity of an LVAD to afterload is higher and the sensitivity to preload 
is lower.34 This small preload sensitivity is the reason why the 
adaptation of the PF to the venous return is limited and suction 
or LV overload can occur. By adapting the PS and indirectly the 
PF to the preload, the physiologic controllers aim at preventing 
suction or LV overload and all their negative consequences.
We conducted acute in vivo experiments with eight healthy 
pigs to compare our two physiologic controllers for LVADs 
with the CS mode. For this purpose, we induced hemodynamic 
changes, whereas the LVAD was operated in one of the three 
control modes. Using a heart-lung machine (HLM) and an 
occlusive balloon catheter placed in the descending aorta, we 
applied acute pre- and afterload changes and observed changes 
of the PS, the PF, and multiple hemodynamic variables. The goal 
of the study was to investigate whether the physiologic control-
lers react to the induced hemodynamic changes as defined by 
the Frank–Starling law and whether they work robustly in vivo.
Materials and Methods
The experiments were conducted with eight pigs 
(m = 91.13 ± 9.69 kg). The animal housing and all procedures 
and protocols were approved by the Cantonal Veterinary Office 
(Zurich, Switzerland) under the license number 152/2013. Hous-
ing and experimental procedures were in accordance with the 
Swiss animal protection law and also conform to Directive 
2010/63 EU of the European Parliament and of the Council of 
September 22, 2010 on the Protection of Vertebrate Animals used 
for Experimental and other Scientific Purposes and also conform 
to the Guide for the Care and Use of Laboratory Animals.
Anesthetic Protocol
After loss of postural reflexes following premedication with 
ketamine (20 mg/kg), azaperone (1.5 mg/kg), and atropine 
(0.75 mg), the anesthesia was deepened by a bolus injection of 
propofol (1–2 mg/kg bodyweight), and the animals were intu-
bated. Anesthesia was then maintained with 2–3% isoflurane 
and propofol (2–5 mg/kg/h). Amiodarone [2–3 mg/kg bolus intra-
venously (iv)] was administered as antiarrhythmic therapy in 
order to stabilize the heart rhythm. Pain management included 
fentanyl (0.02 mg/kg/h) constant rate infusion (CRI) for the dura-
tion of the procedure. After the animals were put on cardio-pul-
monary bypass, isoflurane was discontinued and anesthesia was 
maintained by co-administration of propofol (5 mg/kg/h) and 
fentanyl (0.02 mg/kg/h) CRI. Vital parameters, reflexes, blood-
gases, and acid-base balance were monitored during the whole 
procedure. After completion of the experimental procedure, the 
animals were euthanized by an overdose of Na-pentobarbital.
Surgical Procedure
After induction of anesthesia and placement of the animal 
in supine position, the chest was draped in sterile fashion. 
Following midline skin incision over the sternum, a median 
sternotomy was performed. The pericardium was opened. 
After administration of heparin 300 IE/kg, the aortic arch and 
right atrium were cannulated (Opti22 OptiSite Arterial Can-
nula and TFM324L Venous Cannula, Edwards Lifesciences, 
Irvine, CA) for connection with the HLM (Stöckert SIII, Sorin 
Group Deutschland GmbH, Munich, Germany). The extracor-
poreal circulation was started, keeping normothermic condi-
tions. The ascending aorta was completely mobilized for the 
placement of the flow probe (T-208/24PAU, Transonic Systems, 
Inc., Ithaca, NY). Three ultrasound crystals (UDG, Sonometrics 
Corp., London, Canada) were positioned on the LV for volume 
measurements by using custom-designed, 3D-printed crystal 
holders. The two short-axis crystals were placed in a midven-
tricular position next to the left anterior descending and pos-
terior descending arteries. One of the long-axis crystals was 
positioned at the lateral base of the left ventricle, as counter-
part for the second long-axis crystal that was attached to the 
inflow cannula of the LVAD. Figure 1 illustrates the placement 
of the crystals, the flow probe, and the HLM tubing.
A modified Deltastream DP2 (Xenios AG, Heilbronn, Ger-
many) extracorporeal blood pump was used as an LVAD. The 
motor and the controller of the Deltastream DP2 pump were 
replaced with industrial components (EC 32, maxon motor ag, 
Sachseln, Switzerland/Accelus ASP-090-09, Copley Controls 
Corp., Canton, MA), such that the PS could be controlled as 
desired. An arterial cannula (Opti22 OptiSite) was inserted into 
the ascending aorta, between flow probe and cannula of the 
HLM, serving as outflow graft for the LVAD. Figure 2 shows the 
inflow cannula that was specifically designed for the experi-
ments and 3D-printed with Polyamide 12 (Materialise NV, 
Leuven, Belgium). The inflow cannula contains a through-wall 
recess for a nonmedical grade, digital, barometric pressure sen-
sor KP253 (Infineon Technologies AG, Neubiberg, Germany). 
The sensing surface of the sensor is in direct contact with the 
blood flow, whereas the electrical interconnects on the back-
side were protected by a sealing compound (1-2577 Conformal 
Coating, Dow Corning Corp., Midland, MI).
For implantation of the LVAD inflow cannula, four felt-sup-
ported 3-0 Prolene (Ethicon Inc., Somerville, NJ) U-stitches 
were placed around the left ventricular apex. After incision of 
the apex, a muscular cylinder was excised. The inflow can-
nula was inserted through the apical hole and fixed to the apex 
by placing the Prolene sutures through the implant ring of the 
cannula. The outflow and inflow cannulae were connected to 
the tubing of the LVAD under careful deairing. The LVAD was 
started at 2,000 rpm and the speed was increased whereas the 
flow through the HLM was decreased accordingly. A minimal 
flow of 0.5 L/min was maintained through the HLM to prevent 
flow stasis. As last step, a pigtail catheter (Ventri-Cath 510 
PV Loop Catheter, Millar Instruments Inc., Houston, TX) was 
inserted through the carotid artery into the LV to measure the 
LVP, and a Reliant Stent Graft Balloon Catheter (Medtronic, 
Minneapolis, MN) was placed through the femoral artery into 
the descending aorta for afterload variations.
Physiologic Controllers
In previous publications, we have presented physiologic 
control algorithms based on a measurement of the LVV or 
LVP together with promising in vitro results.31,32 The working 
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principle of both controllers has been described in detail and 
is therefore only summarized here. The purpose of both con-
trollers is the imitation of the Frank–Starling law, that is, the 
adaptation of the PF to the preload of the failing heart.
The PRS controller is operated in the simplified version, where 
the heart rate is not extracted, but is assumed to be constant at 
60 bpm. Five steps are required to compute the desired PS (PSdes) 
based on the measured LVV. First, the LVV signal is low-pass fil-
tered with a second-order infinite impulse response (IIR) filter 
with bandwidth of 2.7 Hz to remove measurement noise. Sec-
ond, the end-diastolic volume (EDV) is extracted from the LVV 
signal by identifying the maximum value from a 1.5 s sliding 
window. Third, the desired hydraulic power of the pump (PPdes) 
is computed by PPdes = kprs × (EDV − EDV0), where kprs = 10 J/L 
is the controller gain and the offset EDV0 is obtained during 
calibration. Fourth, PSdes is computed from PPdes using a static, 
nonlinear mapping, which takes into account the efficiency of 
the pump and the influence of the cannulae on the resistance 
to flow. And fifth, the PSdes is again low-pass filtered with a first-
order IIR filter with a bandwidth of 0.16 Hz.
The SP controller requires four main steps to compute the 
PSdes based on the measured LVP. First, the LVP signal is low-
pass filtered with a first-order IIR filter with bandwidth of 15.9 
Hz to remove measurement noise. Second, the SP is extracted 
from the LVP by identifying the maximum value from a 2 s slid-
ing window. Third, PSdes is computed by PSdes = ksp × (SP – SP0) 
+ PS0, where ksp = 40 rpm/mm Hg is the controller gain, and the 
offset SP0 as well as the reference PS PS0 are obtained during 
calibration. And fourth, the PSdes is again low-pass filtered with 
a first-order IIR filter with a bandwidth of 0.32 Hz.
Finally, depending on the selected controller, the respective 
computed PSdes is fed to the speed controller of the electric 
Figure 1. Illustration of the heart with all implanted cannulas and sensors. The four sonomicrometry ultrasound crystals were placed to 
measure the long and the short axis of the LV. Custom-designed, 3D-printed crystal holders were used to keep three of the crystals fixed in 
an intramural position; the fourth crystal was placed on the inlet cannula of the LVAD. The pigtail catheter for LVP measurement was used in 
case the pump inlet pressure sensor failed. LV, left ventricle; LVAD, left ventricular assist device; LVP, LV pressure.
Figure 2. Three-dimensional-printed LVAD inlet cannula with inte-
grated sensors. LVAD, left ventricular assist device.
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motor of the LVAD. Both physiologic controllers were imple-
mented in Matlab/Simulink and executed on Real-Time Win-
dows Target (The MathWorks Inc., Natick, MA).
Experiments
Three different manipulations were applied to simu-
late hemodynamic changes: a preload reduction, a preload 
increase, and an afterload increase. The preload was reduced 
and increased by draining or infusing 500 ml of blood using the 
HLM. After the preload reduction experiment, the 500 ml were 
infused back into the pig before another 500 ml were infused 
to simulate the preload increase. The afterload was increased 
by inflating the balloon catheter in the descending aorta.
Figure 3 shows an overview of the experimental protocol. With 
each of the eight pigs, two identical blocks of experiments were 
conducted (A and B). At the beginning of each block, the vol-
ume loading of the pig was adjusted to achieve acceptable flow 
and pressure levels, and the controllers were calibrated. For the 
calibration, the pump was set to the CS mode and the speed was 
manually adjusted such that the mean flow through the aortic 
valve was approximately 0.5 L/min and no suction occurred. The 
identified PS was taken as the reference speed for the entire block. 
Then, both physiologic controllers were automatically calibrated, 
that is, the parameter EDV0 of the PRS controller and the parame-
ters SP0 and PS0 of the SP controller were set such that PSdes of both 
controllers corresponded to the reference speed identified before. 
The experiments were then started by randomly selecting one of 
the three controllers and starting with the first manipulation.
Data Recording and Extraction
Table 1 lists all signals that were recorded continuously at 500 
Hz during the experiment. The carotid arterial pressure (CARP) 
was recorded using the ACQ-7700 System (DSI Ponemah, Val-
ley View, OH); all other signals except the LVP were recorded 
using an MF624 input/output card (Humusoft s.r.o, Prague, Czech 
Republic) and Matlab Real-Time Windows Target (The Math-
Works Inc.). The signals from the two recording systems were 
synchronized during postprocessing using a manual trigger signal 
that was recorded on both systems. Because of its digital interface, 
the LVP sensor (KP253) was acquired at 200 Hz using an Arduino 
Due development board (Arduino S.R.L, Scarmagno, Italy), which 
fed the signal to the PC running Matlab Real-Time Windows Tar-
get, where it was upsampled to 500 Hz and recorded. The LVP 
sensor failed in pigs 2 and 5, and in this case we switched to the 
pressure measurement of the pigtail catheter as input for the SP 
controller. Because these two sensors are not placed at the exact 
same position, they do not measure the same signal. Differences 
were observed during suction, when the inlet cannula pressure 
showed negative pressure spikes, but not for the SP that is used 
as input for the SP controller. The LVV was obtained by measur-
ing the short and long axes of the LV with ultrasound crystals and 
computing the volume with an ellipsoid model.
For further analysis, steady-state sections before and after 
each manipulation were extracted. These sections were identi-
fied manually and had duration of at least 10 s. The gray-shaded 
rectangles in Figure 4 indicate the identified steady-state sec-
tions for three preload reduction manipulations. With an 
automatic algorithm, the individual heartbeats within those 
sections were identified and beat-by-beat mean values were 
extracted and stored. From these values, the mean values for 
the entire section were computed for the following signals: PS, 
PF, aortic valve flow (AVF), and CARP. The total cardiac output 
(CO) was computed by adding the mean AVF and PF signals. 
In addition, the beat-by-beat end-diastolic pressure (EDP) was 
identified as the pressure on the bottom right corner of the 
LVP–LVV loop, and the stroke work was extracted by comput-
ing the area inside the pressure–volume loop.
Statistical Analysis
For each manipulation (preload reduction, preload increase, 
and afterload increase) we conducted statistical tests to compare 
the physiologic controllers with the CS mode of the LVAD. We 
computed the change in PS (ΔPS) and the change in PF (ΔPF) 
from before to after the manipulation. Then we used a paired 
t-test to compare each physiologic controller with the CS mode. 
Figure 3. Overview of the study protocol. With all eight pigs, the 
same experiments were conducted once in block A and once in 
block B. In each block, both physiologic controllers and the CS 
mode were tested with all three manipulations, yielding 18 manipu-
lations per pig. The PRS controller is based on LVV; the SP control-
ler is based on LVP. CS, constant speed; LV, left ventricle; LVP, 
LV pressure; LVV, LV volume; PRS, preload responsive speed; SP, 
systolic pressure.
Table 1.  Recorded Signals
Signal Abbreviation Sensor
Left ventricular 
pressure
LVP KP253, Infineon Technologies AG, 
Neubiberg, Germany (pigs 1, 3, 4, 
6, 7, and 8) or
Ventri-Cath 510 PV Loop Catheter/ 
MPVS Ultra PV Loop System, Millar 
Instruments Inc., Houston, TX (pigs 
2 and 5)
Carotid arterial 
pressure
CARP DTXPlus DT-NN, Argon Medical 
Devices Inc., Plano, TX
Left ventricular 
volume
LVV UDG, Sonometrics Corp., London, 
Canada
Pump speed PS Encoder HEDL 5540, maxon motor 
ag, Sachseln, Switzerland
Pump flow PF TS410/ME-11PXL, Transonic 
Systems, Inc., Ithaca, NY
Aortic valve 
flow
AVF T-208/24PAU, Transonic Systems, 
Inc., Ithaca, NY
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We conducted eight tests per manipulation and applied a Bon-
ferroni correction to counteract the problem of multiple tests, 
yielding a significance level of p = 0.05/8 = 0.00625.
Results
In total, 144 preload and afterload manipulations were 
planned (18 manipulations in eight pigs) and 139 were con-
ducted completely. The other five manipulations were either not 
conducted or aborted because of a very low perfusion. Of these 
139 manipulations, 19 were excluded, because no steady-state 
sections could be identified before or after the manipulation. The 
remaining 120 manipulations were used for further analyses.
Qualitative Analysis of Preload Reduction
Figure 4 shows the results of the preload reduction experi-
ment for pig 5, block A with the CS mode and both physiologic 
Figure 4. Example results of the preload reduction experiment (pig 5, block A) with the CS mode and both physiologic controllers. The figure 
shows the PS, the PF, the CO, the LVP, the EDP, and the LVV signals. In addition, the figure depicts pressure–volume loops at steady-state 
conditions before and after the preload decrease for each control mode. The EDV and the SP signals plotted in red are the respective input 
signals to the physiologic controllers. The shaded gray areas indicate the steady-state sections that were used to calculate the mean values 
before and after the manipulations. The preload reduction was started at t = 0 s in all three cases. CO, cardiac output; CS, constant speed; EDP, 
end-diastolic pressure; EDV, end-diastolic volume; LVP, LV pressure; LVV, LV volume; PF, pump flow; PS, pump speed; SP, systolic pressure.
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controllers. The first row shows how both physiologic control-
lers reduce the PS in response to the reduced preload, whereas 
it is kept constant in the CS mode. The PF shown in the second 
row decreases with all three control modes, however, in the CS 
mode it returns to the initial value after 10 s. The small oscilla-
tions in the PS are caused by the mechanical ventilation, which 
influences the LVP and LVV signals.
Hemodynamics During Preload Reduction
Figure 5 shows the mean values of the PS, the PF, the stroke 
work, the CO, the EDP, and the CARP before and after the 
preload reduction experiment from block A for all eight pigs. 
The purpose of this figure is to show the hemodynamic state 
of all pigs and the variability between them, as well as the 
magnitude of the change induced by draining 500 ml of blood. 
Qualitatively, differences between the CS mode and the physi-
ologic controllers can be observed for the PS and PF signals. 
When the pump is operated in CS mode, the PS remains con-
stant and the changes in PF are small. With both physiologic 
controllers, the PS is reduced and the reduction in PF is more 
pronounced. Quantitative values and a statistical analysis are 
provided in the subsequent paragraphs. For the stroke work, 
the CO, the EDP, and the CARP, the qualitative analysis shows 
no difference between the CS mode and the physiologic con-
trollers. The differences between the two physiologic control-
lers are also small for all signals and are overshadowed by the 
inter-animal variability. The results for the preload and after-
load increase experiments can be found in the supplemen-
tary material (see Supplemental Digital Content, http://links.
lww.com/ASAIO/A137), processed in the same manner as the 
results presented in Figure 5.
Statistical Analysis of Pump Speed and Pump Flow
Figure 6 provides a quantitative analysis of the differences 
between the CS mode and the physiologic controllers with a 
statistical analysis of the change of the PS and PF signals during 
the three manipulations. The PS analysis generates five statisti-
cally significant results distributed over all manipulations and 
both controllers. The p value of all comparisons is small and 
all speed changes except of one (afterload increase, SP control-
ler, block A) go in the expected direction. Three PF compari-
sons are statistically significant; none of them for the preload 
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increase manipulation. Table 2 lists the mean and standard 
deviation of ΔPS and ΔPF over both blocks for each manipula-
tion and each control mode. Although both controllers react 
similarly to preload changes, the reaction of the SP controller 
to the afterload increase is stronger.
Preload Sensitivity
In order to investigate whether the reaction of the two con-
trollers to the preload changes is appropriate, we extracted the 
preload sensitivity of the LVAD as the change in PF divided by 
the change in preload ΔPF/ΔEDP. A physiologic preload sensi-
tivity value is reported by Salamonsen et al.34 as 0.21 ± 0.03 L/
min/mm Hg. The values we obtained from the preload reduc-
tion experiment are 0.03 ± 0.08 L/min/mm Hg for the CS 
mode, 0.21 ± 0.29 L/min/mm Hg for the PRS controller, and 
0.26 ± 0.13 L/min/mm Hg for the SP controller.
Ventricular Suction
In total, 34 preload reduction experiments were conducted 
with the pump inlet pressure sensor active and ventricular suc-
tion was observed six times: five times with the CS mode and 
once with the PRS controller. Table 3 lists all suction cases to 
provide an overview of the hemodynamic conditions that pre-
vailed before the preload reduction experiments were started. 
During suction, all signals were highly transient and no steady-
state phase could be identified. Two cases can also be found 
in Figure 5, but the corresponding steady-state sections were 
identified after the suction events.
Discussion
The study results show clearly that both the PRS controller 
as well as the SP controller react to preload changes in the 
expected direction and thereby imitate the Frank–Starling law 
of the heart. Figure 6A, B shows that in response to a preload 
reduction (increase), both controllers reduce (increase) the PS, 
resulting in a reduced (increased) PF. The question whether 
the reaction is adequately strong is answered with the preload 
sensitivity values listed in the Results section paragraph titled 
Preload Sensitivity. Although these numbers are affected by a 
high variance, they indicate that the preload sensitivity of the 
controllers is similar to that of the native heart. The reaction 
of the controllers to the preload increase is weaker than that 
to the preload reduction (Table 2). We believe that this differ-
ence can be explained by the high contractility of the healthy 
Figure 6. Change of the PS (ΔPS) and PF (ΔPF) during the preload reduction, the preload increase, and the afterload increase experiments. 
The values of the PRS and the SP controllers were compared with the values obtained with the CS mode using a paired t-test with a signifi-
cance level of 0.00625. CS, constant speed; PRS, preload responsive speed; SP, systolic pressure.
Table 2.  Mean and Standard Deviation Over Both Blocks
Manipulation
CS Mode PRS Controller SP Controller
ΔPS (rpm) ΔPF (L/min) ΔPS (rpm) ΔPF (L/min) ΔPS (rpm) ΔPF (L/min)
Preload reduction 0 −0.13 ± 0.21 −496 ± 265 −0.68 ± 0.35 −408 ± 198 −0.60 ± 0.28
Preload increase 0 0.10 ± 0.29 241 ± 104 0.36 ± 0.26 279 ± 146 0.39 ± 0.29
Afterload increase 0 −0.57 ± 0.45 263 ± 149 −0.17 ± 0.25 860 ± 373 0.74 ± 0.39
CS, constant speed; PF, pump flow; PRS, preload responsive speed; PS, pump speed; SP, systolic pressure.
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LV, which can fully compensate for the preload increase by 
increasing the AVF, which in turn prevents the controllers to 
increase the PF substantially. A categorization of the two con-
trollers in comparison with others presented in literature can 
be found in a previous publication.32
Most physiologic controllers are designed to prevent suction; 
however, their reaction can be too weak or too slow such that 
suction may still occur. The findings of this study suggest that 
our physiologic controllers are able to prevent suction effec-
tively. The one suction event observed with the PRS controller 
was released after only two heartbeats, which indicates that 
the controller did not fail completely in this case. For a clini-
cal application, the physiologic controllers will be extended 
by an additional suction detection system as proposed in the 
literature.14 In addition, a similar system would intervene when 
the PS is very low or very high over a longer time, indicating 
sensor drift or a similar malfunction. However, in the current 
study we only tested the core algorithm of the control system.
The results of the current study show that the PRS con-
troller also reacts to afterload changes in the expected man-
ner, that is, as defined by the Frank–Starling law. Figure 6C 
shows that when the afterload is increased, the PRS controller 
increases the PS to counteract the decrease in PF. The question 
whether the reaction is adequately strong is easier to answer 
compared with the preload reduction, because we want the 
PF to be insensitive to afterload. With the PRS controller, this 
goal is achieved, as the change in PF almost goes to zero 
(ΔPF = −0.17 ± 0.25 L/min) compared with −0.57 ± 0.45 L/min 
with the CS mode. In contrast, the reaction of the SP control-
ler to an afterload increase is too strong, which results in an 
increase in PF by 0.74 ± 0.39 L/min. This overreaction is clearly 
undesirable as it may lead to excessive arterial pressures. How-
ever, previous in vitro studies have shown that with a weak 
LV and under LVAD support, the SP is less influenced by the 
afterload.32 We therefore assume that with a failing instead 
of a healthy LV, the reaction of the SP controller to afterload 
changes would be more adequate. In general, it remains to 
be determined whether the imitation of the Frank–Starling law 
without taking the perfusion into account explicitly represents 
the optimal physiologic control system.
One important outcome of this study is the proof of the 
robustness of both physiologic controllers: No experiment 
had to be aborted because of a controller problem. In fact, we 
conducted two identical blocks of experiments (A and B) with 
each pig and did not observe any substantially different results. 
The sensors we used to measure the LVV and LVP can only be 
used for acute experiments, but they proved to be sufficiently 
accurate, that is, the accuracy requirements for future biocom-
patible sensor systems are moderate. Clearly, the development 
of reliable, long-term stable implantable sensors is absolutely 
critical for the success of physiologic control. Before the 
second block, we recalibrated both physiologic controllers. 
This procedure was necessary, because the hemodynamics 
changed continuously and the controller settings rendered 
inappropriate after some time. Whereas the hemodynamic 
changes during an acute experiment are presumably different 
from those observed in LVAD patients, a chronic study with 
a physiologic controller is required to answer the question of 
how much recalibration is required. Both physiologic control-
lers also worked well during arrhythmic periods, which were 
observed in two of the eight pigs.
The controller gains need to be selected carefully as a com-
promise between performance and stability. When the gains 
are too low, the difference to the CS mode is negligible; when 
the gains are too high the controllers can become unstable. 
Both controller gain values were selected based on in vitro 
experiments. The gain of the PRS controller additionally allows 
a physiologic interpretation as the slope of the preload recruit-
able stroke work.31,32 In preliminary in vivo experiments, we 
had tested higher and lower gain values. Sustained oscillations 
could be observed with gain values around kprs = 20 J/L and 
ksp = 80 rpm/mm Hg, which indicates that the stability margins 
with the normal gains are approximately 2. With low gains, that 
is, kprs = 5 J/L and ksp = 20 rpm/mm Hg, no substantial differ-
ence to the CS mode could be observed. Therefore, we believe 
that the presented values represent a reasonable compromise 
between a high gain margin and a good preload sensitivity.
Although the current study shows that the reaction of the 
controllers is physiologic, it does not allow a statement on their 
effectiveness in human patients. The results in Figure 5 show 
that the stroke work, the CO, the EDP, and the CARP are all not 
substantially affected by the presence of physiologic control. 
This outcome can be well explained by the healthy pig model 
that was used. Only Schima et al.29 have tested a physiologic 
controller in human patients and they reported a significant 
increase in PF and significant decrease in pulmonary arterial 
pressure in response to physical exercise. The PRS and the SP 
controller are expected to achieve a similar response in human 
patients. However, although those results show that physio-
logic control can improve the hemodynamics, only long-term 
clinical experience will show whether the number of adverse 
events can be reduced.
Table 3.  Suction Cases
Case Control Mode Pig Block
PF Before Suction 
(L/min)
End-Diastolic 
Pressure Before 
Suction (mm Hg)
Duration of Suction 
(s)
1* CS 3 A 1.35 n/a† 5
2 CS 3 B 1.24 n/a† 6
3 CS 4 B 2.21 12.37 7‡
4* PRS 6 A 4.23 2.62 2
5 CS 8 A 2.94 7.56 9
6 CS 8 B 2.75 10.22 5
*These experiment can be found in Figure 5.
†EDP could not be extracted reliably for pig 3 because of the round shape of the pV loop.
‡Then aborted and volume reinfused.
CS, constant speed; PF, pump flow; PRS, preload responsive speed.
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Limitations
The main limitation of the presented study is the use of a 
healthy animal model. Because of the high contractility of the 
healthy LV, the preload sensitivity of the combined heart-LVAD 
system was very high. Consequently, the hemodynamics of our 
model differs substantially from those of a patient suffering from 
heart failure. However, both physiologic controllers have already 
been evaluated in vitro with a HF model.31,32 We expect a similar 
behavior of the controllers in a HF animal model. Furthermore, 
this study represents the first approach to test the two physiologic 
controllers in vivo and because of the complexity, we decided 
not to use pharmacological agents to reduce the contractility or 
to alter the afterload. Future studies, however, will have to be 
conducted with a heart failure animal model that is more com-
plex but represents the clinical situation more accurately.
Another limitation concerns the LVP and LVV sensors we used. 
Not only the ellipsoid model, but also the placement of the sono-
micrometry ultrasound crystals introduced uncertainty on the 
measured LVV. However, the offset of the LVV had no influence 
on the closed-loop system with the PRS controller. Furthermore, 
the lack of long-term stability of both pressure and volume sensors 
constitutes a yet unsolved problem, which hampers the chronic in 
vivo or even clinical implementation of physiologic control. Nev-
ertheless, both sensors served for the purpose of the study, that is, 
for deriving short-term recordings during the acute animal trials 
and, eventually, evaluating the physiologic controllers.
Conclusion
This study shows that both the PRS controller as well as the 
SP controller work robustly in vivo and adapt the PF according 
to the Frank–Starling law of the heart, which strongly reduces 
the risk of ventricular suction or overload.
The effectiveness of the two controllers in reacting to hemo-
dynamic changes is promising. Integrated in an LVAD, they 
may be able to fulfill the needs of physiologic adaptation in the 
clinical setting. Future work is necessary to develop completely 
integrated, long-term stable and biocompatible sensor systems 
feeding the controller with the required LVV or LVP signal.
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